New glasses could slow Kids' worsening eyesight
NCT ID NCT07387159
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests special glasses called MiYOSMART iQ that use tiny lens segments to create a blur signal on the side of the eye, which may slow down the worsening of nearsightedness in children. About 35 kids aged 8-11 will wear these glasses for 6 months, and their results will be compared to a similar group from past data. The goal is to see if these lenses can reduce how much the eye grows longer, which is what makes nearsightedness worse.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MiYOSMART iQ spectacle lenses with Defocus Incorporated Multiple Segments (DIMS) technology
- What this could lead to
- If successful, these lenses could offer a non-invasive way to slow down worsening nearsightedness in children, reducing the need for stronger prescriptions over time.
- What could go wrong
- This is a small, early-stage study with only 35 children receiving the lenses, compared to a historical control group. Results may not apply to all children, and long-term effects beyond 6 months are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA, CHILD MYOPIA PROGRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Helmholtz National Medical Research Center of Eye Diseases
RECRUITINGMoscow, 105062, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.